{"id":425479,"date":"2022-07-30T08:33:22","date_gmt":"2022-07-30T12:33:22","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=425479"},"modified":"2022-07-30T08:34:23","modified_gmt":"2022-07-30T12:34:23","slug":"industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/","title":{"rendered":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Asunci\u00f3n, Agencia IP.-<\/strong> <\/em>El primer anticuerpo monoclonal con sello nacional, destinado a pacientes con tratamiento oncol\u00f3gico, fabricado en el pa\u00eds con tecnolog\u00eda de avanzada, fue lanzado anoche por el Laboratorio de Productos \u00c9ticos, para su l\u00ednea \u201cBio\u00e9ticos\u201d, ante las autoridades nacionales y comunidad m\u00e9dica, en un acto realizado en Puerto Liebig, ubicado en Zeballos Cu\u00e9.<!--more--><\/p>\n<p style=\"text-align: justify;\">El ministro de Industria y Comercio, Luis Alberto Castiglioni, resalt\u00f3 la importancia del innovador medicamento fabricado por una de las industrias nacionales, que apuesta a la inversi\u00f3n constante en el pa\u00eds, y que contribuir\u00e1 al sistema de salud nacional, al garantizar el acceso de los pacientes con c\u00e1ncer, a tratamientos oncol\u00f3gicos de primer nivel, que ayudar\u00e1n a mejorar su calidad de vida.<\/p>\n<p style=\"text-align: justify;\">Luego de dos a\u00f1os de arduo trabajo al m\u00e1s alto nivel t\u00e9cnico, en el que los especialistas biotecn\u00f3logos de Mabxience realizaron la transferencia de tecnolog\u00eda a \u00c9ticos, se presentaron con mucho orgullo los primeros medicamentos biosimilares del Rituximab y Bevacizumab listos para la comercializaci\u00f3n, inform\u00f3 el Ministerio de Industria y Comercio (MIC).<\/p>\n<p style=\"text-align: justify;\">Mabxience es una compa\u00f1\u00eda biotecnol\u00f3gica global a la vanguardia, con m\u00e1s de una d\u00e9cada de experiencia en el desarrollo, fabricaci\u00f3n y comercializaci\u00f3n de productos biofarmac\u00e9uticos. refiere el bolet\u00edn.<\/p>\n<p style=\"text-align: justify;\">La introducci\u00f3n de este medicamento constituye un gran avance para el pa\u00eds, teniendo en cuenta que los anticuerpos monoclonales son de gran importancia para el sistema de salud nacional. De esta manera, el Laboratorio de Productos \u00c9ticos, demuestra su compromiso con la nueva era de la medicina paraguaya, a trav\u00e9s de la innovaci\u00f3n y la tecnolog\u00eda.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asunci\u00f3n, Agencia IP.- El primer anticuerpo monoclonal con sello nacional, destinado a pacientes con tratamiento oncol\u00f3gico, fabricado en el pa\u00eds con tecnolog\u00eda de avanzada, fue lanzado anoche por el Laboratorio de Productos \u00c9ticos, para su l\u00ednea \u201cBio\u00e9ticos\u201d, ante las autoridades nacionales y comunidad m\u00e9dica, en un acto realizado en Puerto Liebig, ubicado en Zeballos Cu\u00e9.<\/p>\n","protected":false},"author":23,"featured_media":425480,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[9],"tags":[12901,6474,3560,10142,12902,317,12903],"class_list":["post-425479","post","type-post","status-publish","format-standard","has-post-thumbnail","category-economia","tag-eticos","tag-industria-farmaceutica","tag-laboratorio","tag-luis-alberto-castiglioni","tag-medicamento-oncologico","tag-mic","tag-productos-eticos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Asunci\u00f3n, Agencia IP.- El primer anticuerpo monoclonal con sello nacional, destinado a pacientes con tratamiento oncol\u00f3gico, fabricado en el pa\u00eds con tecnolog\u00eda de avanzada, fue lanzado anoche por el Laboratorio de Productos \u00c9ticos, para su l\u00ednea \u201cBio\u00e9ticos\u201d, ante las autoridades nacionales y comunidad m\u00e9dica, en un acto realizado en Puerto Liebig, ubicado en Zeballos Cu\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-30T12:33:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-30T12:34:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Noelia Ferreira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Noelia Ferreira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/\"},\"author\":{\"name\":\"Noelia Ferreira\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\"},\"headline\":\"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico\",\"datePublished\":\"2022-07-30T12:33:22+00:00\",\"dateModified\":\"2022-07-30T12:34:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/\"},\"wordCount\":294,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/MIC.jpg\",\"keywords\":[\"\u00c9ticos\",\"industria farmac\u00e9utica\",\"Laboratorio\",\"Luis Alberto Castiglioni\",\"medicamento oncol\u00f3gico\",\"MIC\",\"Productos \u00c9ticos\"],\"articleSection\":[\"Econom\u00eda\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/\",\"name\":\"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/MIC.jpg\",\"datePublished\":\"2022-07-30T12:33:22+00:00\",\"dateModified\":\"2022-07-30T12:34:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/MIC.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/MIC.jpg\",\"width\":1280,\"height\":960,\"caption\":\"El ministro de Industria y Comercio, Luis Alberto Castiglioni particip\u00f3 del evento de lanzamiento del nuevo producto farmac\u00e9utico. Foto: MIC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/30\\\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\",\"name\":\"Noelia Ferreira\",\"sameAs\":[\"http:\\\/\\\/www.ip.gov.py\"],\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/nferreira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/","og_locale":"es_ES","og_type":"article","og_title":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.","og_description":"Asunci\u00f3n, Agencia IP.- El primer anticuerpo monoclonal con sello nacional, destinado a pacientes con tratamiento oncol\u00f3gico, fabricado en el pa\u00eds con tecnolog\u00eda de avanzada, fue lanzado anoche por el Laboratorio de Productos \u00c9ticos, para su l\u00ednea \u201cBio\u00e9ticos\u201d, ante las autoridades nacionales y comunidad m\u00e9dica, en un acto realizado en Puerto Liebig, ubicado en Zeballos Cu\u00e9.","og_url":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2022-07-30T12:33:22+00:00","article_modified_time":"2022-07-30T12:34:23+00:00","og_image":[{"width":1280,"height":960,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg","type":"image\/jpeg"}],"author":"Noelia Ferreira","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Noelia Ferreira","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/"},"author":{"name":"Noelia Ferreira","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2"},"headline":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico","datePublished":"2022-07-30T12:33:22+00:00","dateModified":"2022-07-30T12:34:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/"},"wordCount":294,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg","keywords":["\u00c9ticos","industria farmac\u00e9utica","Laboratorio","Luis Alberto Castiglioni","medicamento oncol\u00f3gico","MIC","Productos \u00c9ticos"],"articleSection":["Econom\u00eda"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/","url":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/","name":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg","datePublished":"2022-07-30T12:33:22+00:00","dateModified":"2022-07-30T12:34:23+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/MIC.jpg","width":1280,"height":960,"caption":"El ministro de Industria y Comercio, Luis Alberto Castiglioni particip\u00f3 del evento de lanzamiento del nuevo producto farmac\u00e9utico. Foto: MIC"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/30\/industria-farmaceutica-nacional-lanzo-innovador-medicamento-oncologico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Industria farmac\u00e9utica nacional lanz\u00f3 innovador medicamento oncol\u00f3gico"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2","name":"Noelia Ferreira","sameAs":["http:\/\/www.ip.gov.py"],"url":"https:\/\/www.ip.gov.py\/ip\/author\/nferreira\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/425479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=425479"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/425479\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/425480"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=425479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=425479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=425479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}